Research graph
References from Pterostilbene attenuates cisplatin-induced acute kidney injury by suppressing TLR4/MyD88/NF-κB signaling. Local targets link to admitted publications; unresolved targets remain external evidence.
Biomarkers for acute kidney injury: a pragmatic approach
10.1007/s00134-026-08296-7 · 2026 · External reference
From “when to stop” to “why continue today?”: operationalizing RRT weaning with UUEI
10.1186/s13054-025-05759-z · 2025 · External reference
OTUD7B attenuates renal fibrosis by regulating PRDX1 protein stability
10.1016/j.jare.2026.02.059 · 2026 · External reference
Acute kidney injury
10.7326/aitc201711070 · 2017 · External reference
Cisplatin in cancer therapy: molecular mechanisms of action
10.1016/j.ejphar.2014.07.025 · 2014 · External reference
JP4-039 mitigates cisplatin-induced acute kidney injury by inhibiting oxidative stress and blocking apoptosis and ferroptosis in mice
10.3390/antiox13121534 · 2024 · External reference
Cisplatin nephrotoxicity: new insights and therapeutic implications
10.1038/s41581-022-00631-7 · 2023 · External reference
Mannitol for prevention of cisplatin-induced nephrotoxicity: a systematic review and meta-analysis of randomized controlled trials
2025 · External reference
Natural products: potential treatments for cisplatin-induced nephrotoxicity
10.1038/s41401-021-00620-9 · 2021 · External reference
New insights into dietary pterostilbene: sources, metabolism, and health promotion effects
10.3390/molecules27196316 · 2022 · External reference
Pterostilbene as a multifaceted anticancer agent: molecular mechanisms, therapeutic potential and future directions
10.1007/s12032-025-02721-5 · 2025 · External reference
Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-β1/TGF-β type I receptor/Smads signaling in proximal tubular epithelial cells
10.1016/j.ejphar.2018.10.008 · 2019 · External reference
Nicotinamide riboside with pterostilbene (NRPT) increases NAD(+) in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
10.1186/s12882-020-02006-1 · 2020 · External reference
10.1186/s12906-017-2055-y
10.1186/s12906-017-2055-y · 2017 · External reference
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF
10.1111/j.1476-5381.2010.00811.x · 2010 · External reference
Ginsenoside Rg5 modulates the TLR4 and BCL-2 pathways by inhibiting NOX1, thereby alleviating inflammation, apoptosis and pyroptosis in hyperuricemia nephropathy
10.1016/j.jgr.2025.03.009 · 2025 · External reference
AMSC-EVs attenuate acute kidney injury through TXNIP-IKKα/NFκB signaling-mediated renal CX3CR1(+) macrophage polarization
10.1186/s13287-025-04754-z · 2025 · External reference
Pterostilbene pre-treatment reduces LPS-induced acute lung injury through activating NR4A1
10.1080/13880209.2022.2034893 · 2022 · External reference
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
10.1016/s2468-1253(25)00006-8 · 2025 · External reference
ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI
10.1080/15548627.2025.2483598 · 2025 · External reference
Transplantation and damage-associated molecular patterns (DAMPs)
10.1111/ajt.13963 · 2016 · External reference
Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis
10.3389/fimmu.2023.1126348 · 2023 · External reference
TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury
10.1042/cs20170262 · 2018 · External reference
Tacrolimus alleviates LPS-induced AKI by inhibiting TLR4/MyD88/NF-κB signalling in mice
10.1111/jcmm.17108 · 2022 · External reference
Forsythiaside A alleviates kidney injury and intestinal epithelium dysfunction in IgA nephropathy by inhibiting TLR4/NF-κB signaling
2026 · External reference
